Pharmafile Logo
Pharmafocus logo
Advanced Search

Neurology

Showing 15 posts of 115 posts found.

brainss

Abbvie acquires Cerevel Therapeutics

August 2, 2024
Mergers and Acquisitions AbbVie, Cerevel Therapeutics, Drug-Resistant Epilepsy, Neurology, Parkinson's disease, major depressive disorder, mergers & acquisitions, neurology, neuroscience, schizophrenia

Abbvie has announced the acquisition of Cerevel Therapeutics, strengthening its neuroscience pipeline. Cerevel has multiple programmes across neurological and psychiatric …

News

Eisai presents latest findings for lecanemab at Alzheimer’s Association International Conference (AAIC)

July 31, 2024
Research and Development Alzheimers, Conference results, Eisai, Neurology

Clarity AD open-label extension (OLE) data show: three years of continuous lecanemab treatment reduced clinical decline by -0.95 vs expected …

News
Press release
alzheimers_brain

AC Immune’s pTau-targeting immunotherapy awarded Fast Track designation by FDA

July 26, 2024
Research and Development AC Immune, Alzheimer's disease, Neurology, clinical trials, fast track designation, immunotherapy, tau protein

Clinical-stage biopharmaceutical company AC Immune announced that the US Food and Drug Administration (FDA) has granted its Alzheimer’s disease (AD) …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

Eisai and EcoNaviSta enter dementia collaboration

July 25, 2024
Business Services EcoNaviSta, Eisai, Neurology, collaboration, dementia

Eisai and EcoNaviSta have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build …

News

J&J seeks FDA approval of Spravato as monotherapy for treatment-resistant depression

July 24, 2024
Medical Communications J&J, Johnson & Johnson, Neurology, Spravato, treatment-resistant depression

Johnson & Johnson (J&J) has announced that it has submitted a supplemental New Drug Application (sNDA) to the US Food …

News

Eli Lilly’s Kisunla approved by FDA for Alzheimer’s treatment

July 3, 2024
Medical Communications Alzheimer's, Eli Lilly, Kisunla, Neurology

Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt, 350mg/20ml once-monthly injection for …

News

NeuroSense shares update from ALS treatment trial

July 2, 2024
Research and Development NeuroSense, Neurology, als, clinical trial

NeuroSense has announced new statistically significant results from the 12-month analysis of its PARADIGM phase 2b study which assessed PrimeC …

News

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024
Research and Development MS, Neurology, Sanofi, multiple sclerosis

Sanofi has announced new phase 2 trial data for its CD40L monoclonal antibody, frexalimab, for the treatment of patients with …

News
robina-weermeijer-so1l3jsdd3y-unsplash_2

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024
Business Services Alzheimers, Biogen, Eisai, Leqembi, Neurology, lecanemab

Eisai and Biogen have announced that Leqembi (lecanemab) has been launched in China as a treatment for mild cognitive impairment …

News
max-bender-w5bn80xghre-unsplash_1

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024
Research and Development AskBio, Neurology, Parkinson's disease, clinical trial

Asklepios BioPharmaceutical (AskBio), a subsidiary of Bayer, has announced that it has initiated the recruitment for its phase 2 REGENERATE-PD …

News

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024
Research and Development CIDP, Hyqvia, Neurology, Takeda, clinical trial

Takeda has announced data from the phase 3 ADVANCE-CIDP 3 trial, which assessed the safety and efficacy of Hyqvia (Immune …

News

Cara Therapeutics shares data from part a of notalgia paresthetica trial

June 13, 2024
Research and Development Cara Therapeutics, Neurology, clinical trial, notalgia paresthetica, pruritus

Cara Therapeutics has announced the outcome from the dose-finding Part A of the KOURAGE-1 study which assessed the efficacy and …

News

Evotec shares progress in Bristol Myers Squibb neuroscience collaboration

June 12, 2024
Research and Development Evotec, Neurology, bristol myers squibb, neuroscience

Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

FDA accepts Eisai’s Leqembi sBLA for early AD treatment

June 11, 2024
Medical Communications Alzheimer's, Biogen, FDA, Neurology, sBLA

Eisai and Biogen have announced that the US Food and Drug Administration (FDA) has accepted Eisai’s supplemental biologics license application …

News

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024
Research and Development NeuroSense, Neurology, als, clinical trials

NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026